---
$id: https://graph.org.ai/products/commodity/51162603
$type: Product
source: UNSPSC
code: "51162603"
title: "Benzonatate"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Benzonatate

**UNSPSC Code**: 51162603
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C12H17NO2(C2H4O)n, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5P4DHS6ENR, chemically known as 2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl p-(butylamino)benzoate but more generally known as benzonatate, which bears US NIH Compound Identifier 7699. European Medicines Agency schedules Benzonatate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05760MIG. The term BENZONATATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules benzonatate in its Anatomical Therapeutic Chemical (ATC) Classification. BENZONATATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule benzonatate under HS 34021300 and SITC 55421. As of Q4 2014, BENZONATATE remains US FDA's Preferred Term for this commodity. Benzonatate bears US NLM identifiers UMLS ID C0053229 and NCI Concept Code C28863. SMILES: CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC.

